Dorly de Freitas Buchi

Homeopathy Science

About Us

Dorly de Freitas Buchi, a renowned Brazilian researcher, holds a Ph.D. in Biological Sciences (Biophysics) from the Federal University of Rio de Janeiro. Her solid academic background is reflected in the publication of several scientific articles in the field of Cell Biology. Professor, for more than 40 years at the Federal University of Paraná, she combines extensive experience in higher education, both in undergraduate and graduate courses, and effective contributions in the sphere of the university administration. Her orientation activities are remarkable, from scientific initiation to doctorate, having promoted the training of a large number of young scientists.

Despite this exemplary academic trajectory, what makes Dorly a special human being are her unique qualities: loyalty, courage, tenderness, and tenacity. Woman, mother, sister, and friend, she is endowed with profound sensitivity, a conciliatory spirit, and the ability to aggregate people and ideals around a greater good. Her respect for life, in all its forms, has always guided her in search of health promotion and a better life for all. And so, in her continuous overcoming of challenges, guided by an acute scientific curiosity and her non-conformity with the paradigms and limitations of traditional medicine, in an untiring spirit and an unwavering purpose of serving collective interests, firmly carried out research based on highly diluted drugs and complex biological response modifiers. A significant part of the results of her efforts and her holistic view is presented in this book which, as an author, proposes to contribute to life, health, and the construction of happiness for all.

About Homeopathy

Immune System and Homeopathy Studies using macrophages treated with different homeopathic medicines have resulted in a significant increase in the activated/resident macrophage ratio compared to control groups (water, hydroalcoholic solution, and untreated). Different macrophage receptors were altered, both in expression and distribution, in addition to altering the production and release of different cytokines and reactive oxygen and nitrogen species…

Last posts we sent to the blog

Homeopathy Science

  • Like cures like: This principle states that a substance that can cause symptoms in a healthy person can cure those same symptoms in a sick person. For example, if a person gets a rash from contact with poison ivy, then a homeopathic remedy made from poison ivy might be used to treat a rash with similar symptoms.

  • The law of minimums: This principle states that the smaller the dose of a remedy, the greater its effect. Homeopathic remedies are often diluted to very high levels, but practitioners believe that this dilution makes them more effective.

  • The single remedy: This principle states that only one remedy should be given at a time, so that its effects can be clearly observed.

  • The totality of symptoms: This principle states that the remedy should be chosen based on the whole picture of the patient’s symptoms, not just the physical symptoms. This includes the patient’s emotional and mental state, as well as their lifestyle and preferences.

My Book on Amazon

To know more about homeoptahy

Visit our blog

The existence and unexpected pathways in my life.

In this book, I tell the story of my life and my relationship with science, and especially how this journey resulted in 20 years of basic research in homeopathy.


Gallusstrasse 1a 8730 Uznach


The coronavirus SARS-CoV-2 has only been circulating in human hosts for a few months,  less than one year, which means that there is simply no way to know whether immunity to the disease lasts longer than that. How long immunity lasts is a big question. Research can only confirm that COVID-19 patients can maintain adaptive immunity to SARS-CoV-2 for few weeks.

Ultimately, researchers are still uncertain about what level of long-term immune memory is enough to protect against future coronavirus infection, and how long it takes for the immune system to drop below that level. It is not even clear whether someone with immunity could spread the coronavirus to others while fighting off a second infection.

Coronaviruses that cause the common cold can infect people repeatedly, as the immunity to other coronaviruses tends to be short-lived, with reinfections happening quite often about 12 months later and, in some cases, even sooner. There is a great chance of the immunity to the novel coronavirus that causes COVID-19 might be similarly short-lived.

The process of developing a vaccine is time-consuming because it requires rigorous scientific evaluation. It is needed to confirm that the vaccine is safety, without many and severe side effects, and is needed to prove its efficacy, more than 50%, in thousand s of people.  

In COVID’s case, they do not even understand the virus itself or how the virus affects the immune system. For example, new dengue vaccine performs well in large trial, but safety remains key concern, because may produce severe side effects and might increasedisease severity, as happened with a dengue vaccine given to 1 million children in the Philippines in 2017.

The exacerbated adaptative immune response against the coronavirus results in inflammation of the lung and blood vessels. But for reasons not yet fully understood, some people enter a vicious cycle, the virus just keeps replicating and the immune system keep calling in for more reinforcements. Them the battle is to control the inflammation.

Unfortunately, against the virus there is not yet a cure. But we can decrease the inflammation or even prevent the disease activating or modulating the innate immune response taking ANBUTA PLUS. So, if you are already infected, you can also help your body to prevent this generalized infection taking ANBUTA PLUS.